Business · 20/07/2004

FDA Proposes Changes to New Drug Application Regulations

The Food and Drug Administration (FDA) is proposing to update its regulations on new drug applications and abbreviated new drug applications to streamline the approval process for new drugs and generic drugs, aiming to meet user fee performance goals set by the Prescription Drug User Fee Amendments of 2002.